@xconomy.com 5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@techcrunch.com 9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs